Skip to main content
. Author manuscript; available in PMC: 2017 Aug 31.
Published in final edited form as: Nat Rev Gastroenterol Hepatol. 2016 Apr 14;13(6):362–374. doi: 10.1038/nrgastro.2016.37

Table 2.

In vivo models for the study of HBV and HCV

Applicability of model Chimpanzees Tupaia Mouse models
Genetically
humanized
model
Stem-cell-
derived human
hepatocytes*
Human
immune
system*
Mouse
immune
system*
HBV infection Yes Yes Not reported Not reported Yes Yes
HCV infection Yes Yes Yes Yes Yes Yes
Liver disease Yes, but mild Yes, but transient Possible No Possible No
Development of immunotherapeutics Yes Yes No No Possible No
Antiviral testing Yes Yes Yes Yes Yes Yes
Vaccine testing Yes No No No Possible No
Availability Very low Low Moderate Low Very low Moderate

Not including HBV-related or HCV-related viruses in other animals models.

*

Xenotransplantation.

Engrafted with primary human hepatocytes.